Personal profile
Personal profile
After completing his postdoctoral training, Dr. Brown joined the faculty at the Baylor College of Medicine as a Clinical Instructor in the Department of Ophthalmology. He received his faculty appointment at the Weill Medical College in 2006.
Research interests
Dr. Brown’s research centers on clinical investigations to evaluate treatments for diabetic retinopathy, neovascular age-related macular degeneration, central retinal vein occlusion, and retinal detachment. Dr. Brown was a key investigator on the Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-related Macular Degeneration (ANCHOR) Study and the Minimally classic/occult trial of the anti-VEGF antibody ranibizumab in the treatment of neovascular AMD (MARINA) Study which both demonstrated a statistically significant benefit of Lucentis (ranibizumab) over Visudyne (verteporfin photodynamic therapy [PDT]) in predominantly classic choroidal neovascularization (CNV). Dr. Brown is also a member of the Diabetic Retinopathy Clinical Research Network.
Education/Academic qualification
Vitreoretinal Diseases & Surgery, Clinical Fellowship
Jul 1 1993 → Jun 30 1995
Award Date: Jun 30 1995
MD, Baylor College of Medicine
May 1 1990 → Jun 1 1994
Award Date: Jun 1 1994
Ophthalmology, Residency, University of Iowa Hospitals and Clinics
Jul 1 1990 → Jun 30 1993
Award Date: Jun 30 1993
Internship, Baylor College of Medicine
Jul 1 1988 → Jun 30 1989
Award Date: Jun 30 1989
Research Area Keywords
- Clinical Care
- Clinical Translation & Trials
Free-text keywords
- Diabetic retinopathy
- Neovascular age-related macular degeneration
- Central retinal vein occlusion
- Retinal detachment
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Ninety-Six-Week Results from the Randomized Phase 2/3 PHOTON Trial
PHOTON Investigators, May 2026, In: Ophthalmology. 133, 5, p. 577-588 12 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Intravitreal aflibercept 8 mg in patients from Japan with diabetic macular edema: 48-week subgroup analysis of the PHOTON trial
the PHOTON Investigators, Jan 2026, In: Japanese Journal of Ophthalmology. 70, 1, p. 123-138 16 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Patient-Reported Experiences and Comfort Associated With Intravitreal Injection Technique: A Cross-Sectional Survey Approach
Afkhamnejad, E. R., Abdullah, Z. A., Nguyen, O. M. Q., Shah, A. R., Rahman, E. Z., Wong, T. P., Chen, E., Wykoff, C. C., Benz, M. S., Pearce, W. A., Nguyen, V. T., Brown, D. M., Kim, R. Y., Fan, K. C., Henry, C. R., Fish, R. H. & Patel, S. B., Jan 1 2026, In: Journal of VitreoRetinal Diseases. 10, 1, p. 57-67 11 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Assessment of Baseline Ultrawidefield Fluorescein Angiographic Quantitative Leakage Parameters with Ultrawidefield Fundus Features and Clinical Parameters in Diabetic Retinopathy in Protocol AA
Writing Committee for the DRCR Retina Network, Mar 2025, In: Ophthalmology Retina. 9, 3, p. 243-252 10 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Link opens in a new tab Scopus citations -
Distinguishing ABCA4 from PRPH2-related disease: qualitative analysis of examination and imaging features
Fan, K. C., Wong, C. W., Nichols, B. A., Sadat, R., Becker, T. C., Brown, D. M. & Wykoff, C. C., 2025, In: Ophthalmic Genetics. 46, 4, p. 347-353 7 p.Research output: Contribution to journal › Article › peer-review
Prizes
-
Presidential Award - High Impact Publication Honoree
Brown, D. M. (Recipient), 2025
Prize: Prize (including medals and awards)